UPDATED Dec 30, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SNDL | US$1.65 | -6.8% | -7.8% | US$424.9m | US$4.81 | PB0.5x | E157.8% | n/a | ||
IXHL | US$0.36 | -12.3% | -83.0% | US$124.7m | n/a | PS10389.7x | E126.5% | n/a | ||
TLRY | US$9.02 | -11.1% | -32.2% | US$1.0b | US$16.17 | PS1.3x | E123.8% | n/a | ||
HBIO | US$0.66 | -9.3% | -68.8% | US$29.3m | US$2.00 | PB2.1x | E121.8% | n/a | ||
AVTR | US$11.47 | 1.8% | -45.6% | US$7.8b | US$13.32 | PS1.2x | E113.7% | n/a | ||
ORGO | US$5.18 | -11.8% | 61.9% | US$657.4m | US$8.50 | PS1.4x | E104.2% | n/a | ||
HYPD | US$3.37 | -16.2% | -71.1% | US$27.5m | US$5.88 | PS79.8x | E97.8% | n/a | ||
AMRN | US$13.51 | -1.4% | 39.3% | US$280.9m | US$12.00 | PS1.2x | E94.5% | n/a | ||
EBS | US$12.16 | -3.0% | 27.2% | US$641.8m | US$13.50 | PE8.4x | E91.3% | n/a | ||
VTRS | US$12.54 | 2.5% | 0.7% | US$14.4b | US$12.44 | PS1x | E85.6% | 3.8% | ||
AYTU | US$2.55 | 0.8% | 50.0% | US$26.0m | US$9.33 | PB1.1x | E83.6% | n/a | ||
SBFM | US$1.23 | -6.1% | -59.0% | US$6.0m | US$6.00 | PB0.2x | E83.5% | n/a | ||
SNOA | US$3.62 | -0.6% | 34.5% | US$6.2m | US$13.40 | PB1.6x | E83.1% | n/a | ||
MDXH | US$3.51 | 1.2% | 48.1% | US$173.7m | US$7.04 | PS1.7x | E81.0% | n/a | ||
AMRX | US$12.88 | 0.08% | 62.6% | US$4.0b | US$14.00 | PE686.3x | E80.1% | 0% | ||
JAGX | US$0.99 | -12.3% | -96.1% | US$4.5m | US$25.50 | PB1.4x | E78.1% | n/a | ||
BRKR | US$47.51 | -1.3% | -19.0% | US$7.2b | US$51.79 | PS2.1x | E73.4% | 0.4% | ||
CLGN | US$1.40 | -4.8% | -61.1% | US$17.9m | US$11.56 | PS7.2x | E73.0% | n/a | ||
HYFT | US$1.73 | 0.3% | 319.0% | US$80.5m | US$4.00 | PS4.1x | E72.7% | n/a | ||
CAI | US$27.32 | -3.3% | n/a | US$7.7b | US$38.11 | PS11.9x | E70.6% | n/a | ||
OGEN | US$0.75 | -9.7% | -93.2% | US$3.1m | US$2.00 | PB0.3x | E69.8% | n/a | ||
SRRA | US$54.99 | 0.06% | 179.4% | US$1.3b | US$55.00 | PB5.1x | E69.5% | n/a | ||
PLX | US$1.74 | -1.7% | -7.4% | US$139.9m | US$11.00 | PE25.9x | E68.7% | n/a | ||
EXAS | US$101.90 | 0.4% | 81.3% | US$19.3b | US$104.56 | PS6.3x | E68.1% | n/a |